Ayal Aizer, MD, MHS, discussed Alliance A071801 data favoring fractionated SRS over single-fraction SRS after brain ...
The FDA has approved pirtobrutinib (Jaypirca) monotherapy as a treatment for adults with previously untreated chronic ...
Fagundes, MD, discussed disease control by risk group among 404 patients with prostate cancer treated with ...
Poster presentations at IMS 2026 highlighted the use of venetoclax, daratumumab, and different combination regimens across ...
Patient enrollment of the phase 3 IDeate-Lung02 trial assessing I-DXd vs chemotherapy in relapsed ES-SCLC will continue ...
Bruce Haffty, MD, and Mutlay Sayan, MD, on building radiation oncology at Rutgers, the future of the field, and a remarkable journey from eastern Turkey to Harvard faculty. In this episode of The ...
Hall, MD, professor and chair of radiation oncology at the Medical College of Wisconsin and medical director of Froedtert ...
In a conversation with CancerNetwork ® at the 23rd Annual International Myeloma Society (IMS) Meeting & Exposition, Jeffrey V. Matous, MD, discussed the feasibility of standardiz ...
Agarwal presented the TALAPRO-3 results at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. Agarwal ...
Resection combined with cesium-131 collagen tile-based radiation therapy (TBRT; GammaTile) significantly improved time to ...
At 8 years, SBRT and radical prostatectomy had similar disease control in the PACE-A trial, with less urinary incontinence ...
Ethan B. Ludmir, MD, explains why advanced radiation techniques like protons fit nonoperative cholangiocarcinoma better than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results